Search | Browse by Day | Author Index

Author Index: P

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Paes, B. A.
  • THE COST-EFFECTIVENESS OF PALIVIZUMAB: A SYSTEMATIC REVIEW OF THE EVIDENCE
  • RESPIRATORY HOSPITALIZATIONS ASSOCIATED WITH PALIVIZUMAB COMPLIANCE IN THE CANADIAN REGISTRY OF SYNAGIS (CARESS)
    • Page, D.
  • MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
    • Palileo, L. M.
  • EFFECTIVENESS OF SHORT MESSAGING SERVICE OF CRITICALLY APPRAISED TOPIC CONCLUSIONS AS A CONTINUING MEDICAL EDUCATION STRATEGY
    • Palma, D. A.
  • STEREOTACTIC BODY RADIOTHERAPY VERSUS SURGERY FOR MEDICALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER: A MARKOV MODEL BASED DECISION ANALYSIS
    • Paltiel, A. D.
  • CONCURRENT ORAL SESSION J: GLOBAL HEALTH AND PREFERENCES
    • Pandharipande, P. V.
  • RADIATION ASSOCIATED WITH CT-GUIDED ABLATION OF RENAL TUMORS: EFFECTS ON PROJECTED LIFE EXPECTANCY
    • Paoli, C. J.
  • COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL OUTCOMES AND COSTS ACROSS TREATMENTS FOR PROSTATE CANCER
    • Papa, F. J.
  • CHANGES IN STRUCTURE OF DIAGNOSIS KNOWLEDGE DUE TO A CHEST PAIN DIAGNOSIS TUTORIAL
  • COMPARISON OF VARIANTS OF A COMPUTERIZED CHEST PAIN DIAGNOSIS TUTOR
    • Pardo, S. T.
  • PREDICTION OF CARDIAC OUTCOMES BY PHYSICIANS VS PRACTICE GUIDELINES
    • Parfrey, P.
  • COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL COMPARING CARE MODELS FOR CHRONIC KIDNEY DISEASE
    • Parkin, P. C.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Parthimos, M.
  • PHARMCOGENETIC TESTING AND EVIDENCE-BASED DECISION-MAKING IN ONTARIO: THE APPLICATION OF ONTARIO'S DECISION DETERMINANTS FRAMEWORK TO THE EVALUATION OF PHARMACOGENETIC TESTS
    • Patel, A. V.
  • COST-EFFECTIVENESS ANALYSIS OF DULOXETINE AND VENLAFAXINE EXTENDED RELEASE FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER (GAD)
    • Patel, V.
  • REVIEW OF PRESCRIPTION MODIFICATIONS: A NOVEL STRATEGY TO ASSESS PHYSICIAN RESPONSE TO MEDICATION ALERTS
    • Paulden, M.
  • THE COST-EFFECTIVENESS ANALYSIS OF FIVE NON-INVASIVE CARDIAC IMAGING TECHNOLOGIES IN ONTARIO
  • PHARMCOGENETIC TESTING AND EVIDENCE-BASED DECISION-MAKING IN ONTARIO: THE APPLICATION OF ONTARIO'S DECISION DETERMINANTS FRAMEWORK TO THE EVALUATION OF PHARMACOGENETIC TESTS
  • A RATIONAL APPROACH FOR DETERMINING THE APPROPRIATE NUMBER OF MONTE CARLO SIMULATIONS REQUIRED IN HEALTH ECONOMIC ANALYSES
    • Peacock, N.
  • CONTRACEPTIVE DECISIONAL CONFLICT: A QUALITATIVE ANALYSIS APPLYING THE OTTAWA DECISION SUPPORT FRAMEWORK TO ASSESS DETERMINANTS OF CONTRACEPTIVE DECISIONS
    • Peacock, S.
  • PRE-MEETING DINNER SYMPOSIUM
    • Pearson, M.
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
    • Pearson, S. D.
  • A COST-EFFECTIVENESS ANALYSIS OF THERAPEUTIC OPTIONS FOR LOW RISK PROSTATE CANCER
    • Peele, P.
  • PREDICTING HOSPITAL READMISSIONS BEFORE THE INITIAL ADMISSION
    • Peeters, Y.
  • FOCUSING ILLUSION AND EQ-5D HEALTH STATE DESCRIPTIONS: PATIENTS VS. PUBLIC
    • Pellerin, M.
  • SHARED DECISION MAKING BEHAVIOURS IN FAMILY MEDICINE RESIDENTS
    • Perkins, S. M.
  • IMPACT OF QUANTITATIVE INFORMATION AND A NUDGE ON ATTITUDES TOWARD COLORECTAL CANCER SCREENING
    • Peters, C. M.
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Petrosyan, V.
  • CONSEQUENCES OF PAYMENT MECHANISMS ON TUBERCULOSIS CONTROL
    • Pham, B.
  • A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL CURVE DATA TO DETERMINE THE EFFECTIVENESS OF LIVER AND KIDNEY TRANSPLANTATION IN PERSONS WITH END-STAGE ORGAN FAILURE AND HUMAN IMMUNODEFICIENCY VIRUS
  • MONTE CARLO APPROACH TO CALIBRATION OF DISEASE HISTORY MODELS FOR HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY
    • Phanuphak, N.
  • ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
    • Philipson, L. H.
  • THE COST-EFFECTIVENESS OF GENETIC SCREENING IN NEONATAL DIABETES
    • Phillips, K.
  • COST-EFFECTIVENESS OF GENE EXPRESSION PROFILING IN EARLY BREAST CANCER
    • Pickles, T.
  • THE IMPACT OF VALUES CLARIFICATION IN A DECISION AID: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL EMERGES SLOWLY OVER TIME
    • Pieterse, A. H.
  • COMMUNICATION ABOUT CANCER PATIENTS' APPRAISAL OF TREATMENT ASPECTS AND ALTERNATIVES: AN EXPLORATIVE STUDY
  • INTRODUCTION TO DESIGNING EVIDENCE-BASED PATIENT DECISION AIDS
    • Pignone, M.
  • CONJOINT ANALYSIS VS. RATING AND RANKING FOR VALUES CLARIFICATION IN COLORECTAL CANCER SCREENING
    • Pineau, J.
  • SET-VALUED DYNAMIC TREATMENT REGIMES
    • Pitsch, R. K.
  • INFORMATION OVERLOAD IN BREAST CANCER DECISION MAKING: WHEN TWO CHOICES ARE TOO MANY
    • Piwko, C.
  • A COST COMPARISON OF OPTIMAL VERSUS SUB-OPTIMAL PRE-DIALYSIS CARE IN CANADA BASED ON THE STARRT TRIAL
    • Plebani, M.
  • LABORATORY ERRORS AND PATIENT SAFETY: THE IFCC WORKING GROUP PROJECT
    • Pleil, A.
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Pliskin, J. S.
  • ARE SECOND-OPINIONS OBJECTIVE? BIASES IN SECOND-OPINION CONSULTATIONS
    • Polisena, J.
  • POLYMERASE CHAIN REACTION TESTS FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN HOSPITALIZED PATIENTS: CLINICAL AND COST-EFFECTIVENESS ANALYSES
    • Politi, M.
  • A CROSS-SECTIONAL STUDY OF YOUNG ADULTS' RESPONSE TO MELANOMA RISK AND PREVENTION MESSAGES
  • CONCURRENT ORAL SESSION C: MEDICAL EDUCATION AND DECISION AIDS
    • Portenoy, A.
  • PREDICTION OF CARDIAC OUTCOMES BY PHYSICIANS VS PRACTICE GUIDELINES
    • Porter, M.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • Pow-Sang, J.
  • PROSTATE CANCER SCREENING CONTROVERSY: A CHALLENGE FOR DECISION AIDS FOR MEN AT HIGH RISK
    • Powell, A. C.
  • THE INFLUENCE OF UNCERTAINTY AND GOALS ON THE ACQUISITION OF A HIGH-TECH DURABLE GOOD: THE CASE OF CT SCANNERS
    • Priest, J. L.
  • THE IMPACT OF DEPRESSION ON MEDICATION ADHERENCE IN A CALIFORNIA MEDICAID POPULATION WITH CARDIOVASCULAR DISEASE
  • FINITE MIXTURE MODELING ANALYSES OF HEALTHCARE UTILIZATION IN PATIENTS WITH TYPE II DIABETES AND COMORBID CARDIOVASCULAR DISEASE
    • Prokopyev, O.
  • OPTIMAL STRAIN SELECTION FOR THE ANNUAL INFLUENZA VACCINE UNDER THE CLOSEST ANTIGENIC DISTANCE IMMUNITY MODEL
    • Pronovost, P. J.
  • DIAGNOSTIC ERROR IN THE PEDIATRIC INTENSIVE CARE UNIT: A SYSTEMATIC REVIEW OF AUTOPSY STUDIES
  • SAFE PATIENTS, SMART HOSPITALS: WHAT CAN THE DEM MOVEMENT LEARN FROM SUCCESSES IN THERAPEUTIC SAFETY?
  • RESEARCH METHODS PANEL DISCUSSION: IS THERE A RIGHT WAY FORWARD?
  • DIAGNOSTIC ERRORS IN ADULT INTENSIVE CARE UNITS: A SYSTEMATIC REVIEW OF AUTOPSY STUDIES
    • Prosser, L.
  • THE IMPACT OF INCREASING DEGREE AND DURATION OF OBESITY AMONG US BIRTH COHORTS ON TYPE 2 DIABETES TRENDS IN THE US
  • THE COST-EFFECTIVENESS OF HIGH FIVE FOR KIDS: A PEDIATRIC PRIMARY CARE OBESITY PREVENTION PROGRAM
  • COMMUNITY-BASED VALUES FOR H1N1 INFLUENZA ILLNESSES AND VACCINATION-RELATED ADVERSE EVENTS
  • EFFECTS ON ILLNESS ON CAREGIVERS AND FAMILIES: A REVIEW OF SPILLOVER EFFECTS IN HEALTH
  • DECISION MAKER PRIORITIES FOR PROVIDING ANTIRETROVIRAL THERAPY IN HIV-INFECTED SOUTH AFRICAN ADULTS: A QUALITATIVE ASSESSMENT
  • TRENDS IN UTILITY ELICITATION METHODS: IS THERE STILL A ROLE FOR DIRECT ELICITATION?
    • Pschirrer, E. R.
  • IS THERE A NEED FOR A PATIENT DECISION AID FOR PRENATAL SCREENING?: PRENATAL PATIENTS' REPORTS ABOUT THEIR DECISION PROCESS
    • Pullenayegum, E.
  • INCORPORATING QUALITY OF LIFE INTO ECONOMIC EVALUATIONS: HEALTH UTILITIES MEASUREMENT
  • USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC) TO THE EQ-5D
  • THE IMPORTANCE OF ADJUSTING FOR POTENTIAL CONFOUNDERS IN BAYESIAN HIERARCHICAL MODELS SYNTHESISING EVIDENCE FROM RANDOMISED AND NON-RANDOMISED STUDIES: A SIMULATION STUDY
    • Purnell, T. S.
  • AN EVIDENCE-BASED FRAMEWORK FOR COMPLEX DECISION MAKING AND QUALITY OF CARE
    • Puthanakit, T.
  • ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
    • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z